Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Ophthalmology

What Triggers Sudden Vision Loss in LHON Carriers?

At a Glance

In LHON, vision loss usually reflects a gradual failure of energy production in vulnerable optic-nerve cells rather than one definite trigger. Smoking is the clearest modifiable risk association, but many carriers have no identifiable trigger, and sudden loss needs urgent assessment.

Living with a mitochondrial DNA variant for Leber Hereditary Optic Neuropathy (LHON) often raises a confusing and frightening question: If I have always carried this genetic variant, why did I just lose my vision now as an adult?

To answer this, it helps to understand how the disease develops. First, what we commonly call “sudden” vision loss in LHON is usually a subacute process—meaning it develops painlessly over days to weeks, often starting in one eye before affecting the other months later [1][2]. The onset of symptoms in adulthood is thought to occur when the cells of the optic nerve can no longer meet their high energy demands, though many people develop symptoms without any identifiable trigger [3].

Urgent Medical Warning: If you experience new, immediate, or rapidly worsening vision loss, seek same-day emergency medical or ophthalmology assessment. Do not assume it is simply LHON. Sudden vision loss can be caused by retinal detachment, stroke, vascular occlusion, or inflammatory optic neuritis, which require urgent diagnosis and treatment [4][2].

The Proposed “Metabolic Reserve” Model

LHON is caused by genetic variants in your mitochondrial DNA, not a single nuclear gene [5]. Mitochondria are the “powerhouses” of your cells, responsible for producing energy in the form of a molecule called ATP. The LHON variants make mitochondria less efficient at producing ATP and can increase oxidative stress (cellular damage from reactive oxygen molecules) [5][6].

However, carrying a LHON variant involves incomplete penetrance, meaning many carriers will never develop vision loss [7]. Researchers propose a “metabolic threshold” or “bioenergetic reserve” model to explain why symptoms appear later in life [3]. According to this hypothesis, your cells can compensate for the impaired mitochondria for years. The cells of the optic nerve (specifically the retinal ganglion cells) require massive amounts of energy to transmit visual information to the brain [8]. The hypothesis suggests that vision loss begins when a combination of biological factors and external stressors depletes this energetic reserve, and the cells can no longer function [3][9].

Importantly, there is no routine test to measure a person’s “metabolic reserve,” and onset is not like a simple switch. It is important to know that you did not cause your vision loss by making a single wrong lifestyle choice, as many patients have no clear trigger [6].

Potential Environmental Modifiers

While scientists cannot predict exactly when or if a carrier will develop symptoms, observational human studies and laboratory research have identified several environmental factors that are associated with an increased risk of LHON conversion. Avoiding these factors is generally recommended, though it does not guarantee prevention [10].

  • Smoking (Tobacco): Smoking has the strongest observational association with LHON vision loss. Studies show that smoking is significantly more common among people who develop symptoms than those who carry the variant but remain asymptomatic [11]. In laboratory settings, cigarette smoke reduces mitochondrial energy (ATP) in LHON-mutated cells [12].
  • Heavy Alcohol Consumption: Excessive alcohol use has also been observed more frequently in symptomatic LHON patients in some cohorts, though its independent role is less clearly established than smoking [11][13]. Reducing alcohol intake is considered a sensible precaution [14].
  • Toxic Exposures and Medications: Certain medications and industrial toxins can interfere with mitochondrial function. However, evidence linking specific drugs to LHON onset is mostly limited to isolated case reports or laboratory studies [15][16]. For example, laboratory cell studies suggest that benzalkonium chloride (a common eye drop preservative) can negatively affect LHON-mutated cells, but this has not been proven to cause vision loss in human patients [17]. Never stop or change prescribed medications or eye drops without consulting your prescribing doctor or pharmacist.
  • Vitamin B12 Deficiency: Vitamin B12 is essential for nerve health, and its deficiency can independently cause optic neuropathy. While one study found B12 deficiency in 21% of LHON carriers under 65, the rates were not significantly different between symptomatic patients and asymptomatic carriers [13]. Therefore, B12 deficiency is not a proven trigger for LHON, but targeted testing by a clinician can identify if you need supplements for general nerve health [13].
  • Physical or Metabolic Stress: Major physical stressors—such as an acute illness, high fever, or severe infection—have been reported anecdotally to precede vision loss in some cases. It is hypothesized that these events drastically increase the body’s energy demands, but human evidence confirming these as reliable triggers is limited [9].

Biological Modifiers

Inherent biological factors also modify the risk of developing symptoms, helping to explain why relatives with the same mitochondrial variant might have completely different outcomes:

  • Biological Sex: LHON has a much higher penetrance in men than in women (an estimated 17.5% risk in males versus 5.4% in females in one registry) [7]. Researchers hypothesize that estrogen may offer a protective effect against mitochondrial damage, though this remains a proposed explanation and is not a basis for self-directed hormone treatment [10][6].
  • Mitochondrial Haplogroups: A haplogroup is a specific background pattern of genetic variations in your mitochondrial DNA. Certain haplogroups can either subtly protect cells or make them more vulnerable, influencing the overall risk of conversion [7][10].
  • Age: While LHON often strikes in young adulthood, it can occur in older adults [4]. Some scientists propose that the natural, age-related decline in mitochondrial function may eventually contribute to depleting a carrier’s metabolic reserve [3].

Common questions in this guide

Is smoking a trigger for vision loss in LHON?
Smoking has the strongest observational association with developing vision loss among people who carry an LHON mitochondrial variant. Stopping tobacco is recommended, but quitting cannot guarantee that vision loss will be prevented.
Can heavy alcohol use bring on LHON vision loss?
Heavy alcohol use has been reported more often in some people with symptomatic LHON, but its independent effect is less certain than smoking. Reducing excessive alcohol intake is a sensible precaution, and a clinician can help if cutting back is difficult.
Why does LHON cause vision loss years after someone inherits the variant?
LHON has incomplete penetrance, so many carriers never develop symptoms. Researchers think optic-nerve cells may compensate for reduced mitochondrial energy production until biological factors or stressors exhaust that reserve, but a specific trigger is often not found.
Is vision loss from LHON truly sudden?
LHON vision loss is usually painless and develops over days to weeks, so it is often subacute rather than instantaneous. It commonly starts in one eye and may affect the other months later, but immediate or rapidly worsening vision loss needs same-day assessment because it may have another urgent cause.
Should I review my medicines or get tested for vitamin B12 if I carry LHON?
Ask your doctor or pharmacist to review your medicines rather than stopping anything yourself, because evidence for specific medication triggers is limited and varies. Vitamin B12 deficiency can independently affect the optic nerve, but it is not a proven trigger for LHON; targeted testing may be appropriate based on your health and diet.
What should I do if I develop new or rapidly worsening vision loss?
Seek same-day emergency or ophthalmology assessment and do not assume the change is caused by LHON. Retinal detachment, stroke, a blocked blood vessel, and inflammatory optic neuritis can also cause sudden vision loss and require urgent diagnosis.

Get notified when new evidence is published on Leber hereditary optic neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Atypical Leber hereditary optic neuropathy with a 34-year interval between vision loss in both eyes.

    Sugiura K, Ishimaru S, Fukuda K

    American journal of ophthalmology case reports 2022; (25()):101263 doi:10.1016/j.ajoc.2022.101263.

    PMID: 35112015
  2. 2

    Leber hereditary optic neuropathy presenting as bilateral visual loss and white matter disease.

    Algahtani H, Shirah B, Abdulkareem AA, et al.

    Bioinformation 2023; (19(3)):226-229 doi:10.6026/97320630019226.

    PMID: 37808372
  3. 3

    Bioactivity and gene expression profiles of hiPSC-generated retinal ganglion cells in MT-ND4 mutated Leber's hereditary optic neuropathy.

    Wu YR, Wang AG, Chen YT, et al.

    Experimental cell research 2018; (363(2)):299-309 doi:10.1016/j.yexcr.2018.01.020.

    PMID: 29366807
  4. 4

    Recognizing Leber's Hereditary Optic Neuropathy to avoid delayed diagnosis and misdiagnosis.

    La Morgia C, Cascavilla ML, De Negri AM, et al.

    Frontiers in neurology 2024; (15()):1466275 doi:10.3389/fneur.2024.1466275.

    PMID: 39364415
  5. 5

    Leber Hereditary Optic Neuropathy-Light at the End of the Tunnel?

    Kim US, Jurkute N, Yu-Wai-Man P

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; (7(4)):242-245 doi:10.22608/APO.2018293.

    PMID: 30008192
  6. 6

    ["Triple-hit" pathogenic mechanism of Leber hereditary optic neuropathy].

    Wang K, Li S, Zhang Y, Guan M

    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2026; (55(7)):683-690 doi:10.3724/zdxbyxb-2025-0868.

    PMID: 42260285
  7. 7

    Establishing risk of vision loss in Leber hereditary optic neuropathy.

    Lopez Sanchez MIG, Kearns LS, Staffieri SE, et al.

    American journal of human genetics 2021; (108(11)):2159-2170 doi:10.1016/j.ajhg.2021.09.015.

    PMID: 34670133
  8. 8

    A neurodegenerative perspective on mitochondrial optic neuropathies.

    Yu-Wai-Man P, Votruba M, Burté F, et al.

    Acta neuropathologica 2016; (132(6)):789-806 doi:10.1007/s00401-016-1625-2.

    PMID: 27696015
  9. 9

    OXPHOS bioenergetic compensation does not explain disease penetrance in Leber hereditary optic neuropathy.

    Lopez Sanchez MIG, Van Bergen NJ, Kearns LS, et al.

    Mitochondrion 2020; (54()):113-121 doi:10.1016/j.mito.2020.07.003.

    PMID: 32687992
  10. 10

    Leber hereditary optic neuropathy: bridging the translational gap.

    Jurkute N, Yu-Wai-Man P

    Current opinion in ophthalmology 2017; (28(5)):403-409 doi:10.1097/ICU.0000000000000410.

    PMID: 28650878
  11. 11

    Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber's Hereditary Optic Neuropathy mutation carriers: a prospective cohort study.

    Rabenstein A, Catarino CB, Rampeltshammer V, et al.

    Orphanet journal of rare diseases 2021; (16(1)):127 doi:10.1186/s13023-021-01724-5.

    PMID: 33706792
  12. 12

    Cigarette toxicity triggers Leber's hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways.

    Giordano L, Deceglie S, d'Adamo P, et al.

    Cell death & disease 2015; (6()):e2021 doi:10.1038/cddis.2015.364.

    PMID: 26673666
  13. 13

    Vitamin B12 in Leber hereditary optic neuropathy mutation carriers: a prospective cohort study.

    Zibold J, von Livonius B, Kolarova H, et al.

    Orphanet journal of rare diseases 2022; (17(1)):310 doi:10.1186/s13023-022-02453-z.

    PMID: 35945620
  14. 14

    Leber's hereditary optic neuropathy: Update on current diagnosis and treatment.

    Esmaeil A, Ali A, Behbehani R

    Frontiers in ophthalmology 2022; (2()):1077395 doi:10.3389/fopht.2022.1077395.

    PMID: 38983564
  15. 15

    Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy.

    Reinert MC, Pacheu-Grau D, Catarino CB, et al.

    Orphanet journal of rare diseases 2021; (16(1)):64 doi:10.1186/s13023-021-01690-y.

    PMID: 33541401
  16. 16

    Food derived respiratory complex I inhibitors modify the effect of Leber hereditary optic neuropathy mutations.

    López-Gallardo E, Emperador S, Hernández-Ainsa C, et al.

    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2018; (120()):89-97 doi:10.1016/j.fct.2018.07.014.

    PMID: 29991444
  17. 17

    The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells.

    Datta S, Baudouin C, Brignole-Baudouin F, et al.

    Investigative ophthalmology & visual science 2017; (58(4)):2406-2412 doi:10.1167/iovs.16-20903.

    PMID: 28444329

This page explains proposed triggers and risk modifiers for LHON for informational purposes only and does not replace medical advice. New or rapidly worsening vision loss needs same-day emergency or ophthalmology assessment.